Open AccessAnti-Human Leukocyte Antigen Antibodies are Associated with Restenosis after Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy
Author(s) -
Matthew McKay,
Sean Pinney,
Simon Gorwara,
Elizabeth Burke,
Robert R. Sciacca,
Mark Apfelbaum,
Donna Mancini,
Silviu Itescu,
LeRoy E. Rabbani
Publication year - 2005
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000160814.49893.fa
Subject(s) - restenosis , medicine , conventional pci , percutaneous coronary intervention , cardiology , population , angioplasty , stenosis , transplantation , stent , myocardial infarction , environmental health
Percutaneous coronary intervention (PCI) to palliate cardiac allograft vasculopathy (CAV) has been associated with high restenosis rates, possibly related to increased inflammation associated with this disease. Whether markers of immunologic rejection are associated with restenosis in this population is unknown. The goal of the study was to determine the predictors of restenosis after PCI for CAV.